These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 26271342)
1. Haploinsufficiency of interferon regulatory factor 4 strongly protects against autoimmune diabetes in NOD mice. Akazawa S; Kobayashi M; Kuriya G; Horie I; Yu L; Yamasaki H; Okita M; Nagayama Y; Matsuyama T; Akbari M; Yui K; Kawakami A; Abiru N Diabetologia; 2015 Nov; 58(11):2606-14. PubMed ID: 26271342 [TBL] [Abstract][Full Text] [Related]
2. Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice. Tan Q; Tai N; Li Y; Pearson J; Pennetti S; Zhou Z; Wong FS; Wen L JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321370 [TBL] [Abstract][Full Text] [Related]
3. Impact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice. Kim D; Lee SM; Jun HS Immunol Cell Biol; 2017 Mar; 95(3):287-296. PubMed ID: 27686408 [TBL] [Abstract][Full Text] [Related]
4. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. Inoue Y; Kaifu T; Sugahara-Tobinai A; Nakamura A; Miyazaki J; Takai T J Immunol; 2007 Jul; 179(2):764-74. PubMed ID: 17617565 [TBL] [Abstract][Full Text] [Related]
5. Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b. Zerif E; Khan FU; Raki AA; Lullier V; Gris D; Dupuis G; Amrani A Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899608 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice. Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485 [TBL] [Abstract][Full Text] [Related]
7. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways. Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441 [TBL] [Abstract][Full Text] [Related]
8. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095 [TBL] [Abstract][Full Text] [Related]
9. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534 [TBL] [Abstract][Full Text] [Related]
10. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1. Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120 [TBL] [Abstract][Full Text] [Related]
11. Development of insulitis and diabetes in B cell-deficient NOD mice. Yang M; Charlton B; Gautam AM J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752 [TBL] [Abstract][Full Text] [Related]
12. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major. Akbari M; Honma K; Kimura D; Miyakoda M; Kimura K; Matsuyama T; Yui K J Immunol; 2014 Mar; 192(5):2271-9. PubMed ID: 24489086 [TBL] [Abstract][Full Text] [Related]
13. Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse. Kuriya G; Uchida T; Akazawa S; Kobayashi M; Nakamura K; Satoh T; Horie I; Kawasaki E; Yamasaki H; Yu L; Iwakura Y; Sasaki H; Nagayama Y; Kawakami A; Abiru N Diabetologia; 2013 Aug; 56(8):1773-80. PubMed ID: 23699989 [TBL] [Abstract][Full Text] [Related]
14. Essential role of interferon regulatory factor 4 (IRF4) in immune cell development. Nam S; Lim JS Arch Pharm Res; 2016 Nov; 39(11):1548-1555. PubMed ID: 27826752 [TBL] [Abstract][Full Text] [Related]
15. Targeting IRF4 in autoimmune diseases. Xu WD; Pan HF; Ye DQ; Xu Y Autoimmun Rev; 2012 Oct; 11(12):918-24. PubMed ID: 23010632 [TBL] [Abstract][Full Text] [Related]
16. CHOP deletion does not impact the development of diabetes but suppresses the early production of insulin autoantibody in the NOD mouse. Satoh T; Abiru N; Kobayashi M; Zhou H; Nakamura K; Kuriya G; Nakamura H; Nagayama Y; Kawasaki E; Yamasaki H; Yu L; Eisenbarth GS; Araki E; Mori M; Oyadomari S; Eguchi K Apoptosis; 2011 Apr; 16(4):438-48. PubMed ID: 21274633 [TBL] [Abstract][Full Text] [Related]
17. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066 [TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Khil LY; Jun HS; Kwon H; Yoo JK; Kim S; Notkins AL; Yoon JW Diabetologia; 2007 Oct; 50(10):2147-55. PubMed ID: 17676307 [TBL] [Abstract][Full Text] [Related]
19. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666 [TBL] [Abstract][Full Text] [Related]
20. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Mariño E; Walters SN; Villanueva JE; Richards JL; Mackay CR; Grey ST Eur J Immunol; 2014 Apr; 44(4):983-93. PubMed ID: 24435807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]